Multiple Dose Safety, Tolerability, PK，PD and Food Effect Study of HEC96719 in Healthy Adult Subjects
NCT04546984 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 66
Last updated 2021-05-07
Summary
The Safety, Tolerability, Pharmacokinetic, Pharmacodynamics and Food Effect Study of HEC96719 in Healthy Subjects
Conditions
- Nonalcoholic Steatohepatitis (NASH)
Interventions
- DRUG
-
HEC96719
Part 2：Mulltiple doses up to 10 days
Sponsors & Collaborators
-
Sunshine Lake Pharma Co., Ltd.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-09-14
- Primary Completion
- 2020-12-29
- Completion
- 2020-12-29
Countries
- China
Study Locations
More Related Trials
-
A Phase I Study to Assess the Safety,Tolerability, PK, PD, and Food Effect of HSK44459 in Healthy Subjects
NCT06858657 ·Status: COMPLETED ·Phase: PHASE1
-
The Study of a Selective 5-ht6 Receptor Antagonist, HEC30654AcOH,in Healthy Subjects
NCT03655873 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability,PK/PD, Food Effect of Single and Multiple Ascending Doses of HSK31858 in Healthy Volunteers
NCT05663593 ·Status: COMPLETED ·Phase: PHASE1
-
HEC53856 Phase 1 Study - Single and Multiple Oral Dosing in Healthy Volunteers
NCT03886688 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BLD-0409 in Healthy Subjects
NCT04146805 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate Safety, Tolerability and Pharmacokinetics of ASC42 in Chinese Healthy Subjects
NCT04965337 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability and Pharmacokinetics of Single and Multiple Oral Administration of HS-10356 in Healthy Volunteers
NCT04652297 ·Status: UNKNOWN ·Phase: PHASE1
-
The Safety, Tolerability, and Pharmacokinetics of SYHX1901 Tablets in Chinese Healthy Subjects
NCT04880512 ·Status: UNKNOWN ·Phase: PHASE1
-
This Study is to Evaluate the Safety, Tolerability, and Pharmacokinetics (PK) of HSK47388 in Healthy Volunteers
NCT06926218 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
A Phase I Study to Assess the Safety,Tolerability, PK, PD, and Food Effect of HSK39297 in Healthy Subjects
NCT06350279 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate HT-4253 in Healthy Subjects
NCT06537817 ·Status: COMPLETED ·Phase: PHASE1
-
A Research Study Looking at How the Medicine NNC0194-0499 Behaves in Japanese and Non-Asian Men
NCT04722653 ·Status: COMPLETED ·Phase: PHASE1
-
Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of HEC73077 in Healthy Subjects
NCT05492630 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I Study Evaluating the Safety, Tolerability, PK and PD in Healthy Chinese Volunteers
NCT03971916 ·Status: COMPLETED ·Phase: PHASE1
-
A Single and Multiple Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of AZD8965 in Healthy Participants (Including Japanese and Chinese Participants) and an Open-label Cohort to Assess the Effect of Food on the Pharmacokinetics of AZD8965 in Healthy Participants
NCT06502379 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Understand the Safety, Tolerability, and Activity of Drug in Body Over a Period of Time of AZD2693, in Subjects of Non-Childbearing Potential in Overweight But Otherwise Healthy Subjects, and Healthy Chinese and Japanese Subjects
NCT04142424 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, and Pharmacokinetics of EQU-001 in Healthy Volunteers
NCT05004571 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I Study to Investigate the Safety, Tolerability and Pharmacokinetic Profile of SNP-630 in Health Subjects.
NCT04808154 ·Status: COMPLETED ·Phase: PHASE1
-
The PK/PD Study of SHR7280 Tablets in Healthy Subjects.
NCT04554043 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability and Pharmacokinetics of FTP-198 in Healthy Australian Volunteers
NCT04526496 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of the Safety, Tolerability and Pharmacokinetics of HY8931 in Healthy Adult Participants
NCT07281703 ·Status: RECRUITING ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HS-20004 in Healthy Chinese Volunteers
NCT02746302 ·Status: COMPLETED ·Phase: PHASE1
-
Ascending Single-Dose and Multiple-Dose Study to Evaluate HSK31679 in Healthy Subjects and Subjects With Elevated LDL-C
NCT05531097 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Safety and Tolerability of Single and Multiple Ascending Doses of Oral RO7020531 in Chinese Healthy Participants.
NCT03530917 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability and PK/PD of SHR1459 in Healthy Volunteers
NCT03668509 ·Status: UNKNOWN ·Phase: PHASE1